NQMC Update Service: May 30, 2016

National Quality Measures Clearinghouse (NQMC)

May 30, 2016

New This Week

Measure Summaries

American Society of Anesthesiologists

Department of Veterans Affairs PROMISE Center

Withdrawn Summaries

The measure summaries listed below have been withdrawn from the NQMC Web site because they are no longer in current use and therefore, do not meet the NQMC Inclusion Criteria. Please see the Measure Archive for a complete list of measures that have been withdrawn from the NQMC Web site.

American Society of Anesthesiologists

  • Anesthesiology and critical care: percentage of patients, regardless of age, undergoing surgical or therapeutic procedures under general or neuraxial anesthesia of 60 minutes duration or longer for whom either active warming was used intraoperatively for the purpose of maintaining normothermia, OR at least one body temperature equal to or greater than 36 degrees Centigrade (or 96.8 degrees Fahrenheit) was recorded within 30 minutes immediately before or the 15 minutes immediately after anesthesia end time.

RAND Corporation

  • Carpal tunnel syndrome (CTS): percentage of eligible patients for whom a provider who treats musculoskeletal disorders has not documented that carpal tunnel surgery is contraindicated because the patient has diabetes.
  • Carpal tunnel syndrome (CTS): percentage of eligible patients for whom a suspicion of CTS was explicitly documented in the medical record at or before the visit at which a provider first evaluated the finger symptoms.
  • Carpal tunnel syndrome (CTS): percentage of eligible patients for whom at least two of the following were documented in the medical record for the initial evaluation visit: location, quality, duration, and onset.
  • Carpal tunnel syndrome (CTS): percentage of eligible patients for whom CTS was mentioned in the progress note from a follow-up visit with a provider who treats musculoskeletal disorders within 4 weeks of the visit at which the CTS symptoms were first described as work associated.
  • Carpal tunnel syndrome (CTS): percentage of eligible patients for whom height and weight or a clinical judgment about presence or absence of obesity/overweight are documented in the medical record for the initial evaluation visit.
  • Carpal tunnel syndrome (CTS): percentage of eligible patients for whom no provider documented that they prescribed diuretics as treatment for CTS symptoms.
  • Carpal tunnel syndrome (CTS): percentage of eligible patients for whom no provider documented that they prescribed muscle relaxants as treatment for CTS symptoms.
  • Carpal tunnel syndrome (CTS): percentage of eligible patients for whom no provider documented that they prescribed opiates (opioids) as treatment for CTS symptoms.
  • Carpal tunnel syndrome (CTS): percentage of eligible patients for whom no provider documented that they prescribed or recommended NSAIDs as treatment for CTS symptoms.
  • Carpal tunnel syndrome (CTS): percentage of eligible patients for whom no provider has documented that they prescribed or administered laser therapy as treatment for CTS symptoms.
  • Carpal tunnel syndrome (CTS): percentage of eligible patients for whom one or more of the specified criteria regarding MRI or CT testing is documented in the medical record.
  • Carpal tunnel syndrome (CTS): percentage of eligible patients for whom one or more risks of steroids (or prior receipt of steroids) were documented in the medical record as having been discussed within six weeks before the steroids were administered or prescribed.
  • Carpal tunnel syndrome (CTS): percentage of eligible patients for whom the medical record documents that at least one of the following physical examination maneuvers was performed during the visit: testing for sensory abnormalities in median nerve distribution, testing for thenar muscle weakness, and examination for thenar muscle atrophy.
  • Carpal tunnel syndrome (CTS): percentage of eligible patients for whom the medical record for the visit at which splints were first prescribed, or any subsequent visits occurring within six weeks, documented that the splint was prescribed for at least six weeks.
  • Carpal tunnel syndrome (CTS): percentage of eligible patients for whom the medical record from the visit documented that at least one diagnosis other than CTS was evaluated.
  • Carpal tunnel syndrome (CTS): percentage of eligible patients for whom the physician administering or prescribing steroids documented a follow-up call or visit with the patient within four weeks.
  • Carpal tunnel syndrome (CTS): percentage of eligible patients for whom the presence or absence of at least one of the following risk factors was documented in the medical record at the initial evaluation or two subsequent CTS-related visits: rheumatoid or other arthritis, diabetes mellitus, hypothyroidism, pregnancy, and chronic renal failure.
  • Carpal tunnel syndrome (CTS): percentage of eligible patients for whom the presence or absence of at least one of the specified non-occupational exacerbating factors is documented in the medical record from the time of the initial evaluation of the CTS symptoms through the two subsequent CTS-related visits.
  • Carpal tunnel syndrome (CTS): percentage of eligible patients for whom the presence or absence of at least one of the specified occupational exacerbating factors is documented from the time of the initial evaluation of the CTS symptoms through the two subsequent CTS-related visits.
  • Carpal tunnel syndrome (CTS): percentage of eligible patients for whom the progress notes from the visit document the presence or absence of at least one of the following: trauma, deformity, and fever.
  • Carpal tunnel syndrome (CTS): percentage of eligible patients for whom there is documentation in the medical record of at least one of the specified pieces of history from the time of the initial evaluation of the CTS symptoms through the two subsequent CTS-related visits.
  • Carpal tunnel syndrome (CTS): percentage of eligible patients having documentation in the medical record that activity modification was discussed with the patient at the visit at which the exposures to mechanical force, vibration, or frequent repetitive wrist movements were first documented.
  • Carpal tunnel syndrome (CTS): percentage of eligible patients having documentation in the medical record that within the first four weeks after the diagnosis of CTS a provider who treats musculoskeletal disorders educated them about CTS.
  • Carpal tunnel syndrome (CTS): percentage of eligible patients having documentation in the six weeks before or at the visit, by the provider who prescribed/administered the steroids, that he or she discussed surgery with the patient.
  • Carpal tunnel syndrome (CTS): percentage of eligible patients who are off work for four or more weeks for CTS-related symptoms for whom the visit note documented the presence or absence of one or more of the following: 1) alcohol or substance abuse, 2) depression or anxiety, or 3) other barriers to return to work.
  • Carpal tunnel syndrome (CTS): percentage of eligible patients who had a follow-up visit to a provider who treats musculoskeletal disorders within four weeks of returning to work and for whom the provider's note for this visit documented the presence or absence of occupational functional limitations.
  • Carpal tunnel syndrome (CTS): percentage of eligible patients who have documentation in the medical record by the second CTS-related visit after the diagnosis indicating a provider's opinion of the probability that the CTS is work associated and a rationale for that judgment.
  • Carpal tunnel syndrome (CTS): percentage of eligible patients who have either four or fewer injections in the study hand before the end of the study period or five or more injections in the study hand before the end of the study period and documented refusal of surgery during the six months before the fifth injection.
  • Carpal tunnel syndrome (CTS): percentage of eligible patients whose CTS symptoms worsened after the closed reduction of a wrist fracture or immobilization of the wrist and who underwent carpal tunnel surgery within 48 hours, or for whom refusal of surgery was documented within 48 hours, of the reduction or immobilization.
  • Carpal tunnel syndrome (CTS): percentage of eligible patients whose medical record for the visit at which the splint was first prescribed documented that the splint was adjusted so that the wrist was in neutral position.
  • Carpal tunnel syndrome (CTS): percentage of eligible patients with mild CTS who did not undergo carpal tunnel surgery during the study period (part I).
  • Carpal tunnel syndrome (CTS): percentage of eligible patients with mild CTS who did not undergo carpal tunnel surgery during the study period (part II).
  • Carpal tunnel syndrome (CTS): percentage of eligible patients with mild CTS who underwent carpal tunnel surgery, or were offered it and declined.
  • Carpal tunnel syndrome (CTS): percentage of eligible patients with moderate CTS who did not undergo carpal tunnel surgery during the study period (part I).
  • Carpal tunnel syndrome (CTS): percentage of eligible patients with moderate CTS who did not undergo carpal tunnel surgery during the study period (part II).
  • Carpal tunnel syndrome (CTS): percentage of eligible patients with moderate CTS who did not undergo carpal tunnel surgery during the study period (part III).
  • Carpal tunnel syndrome (CTS): percentage of eligible patients with moderate CTS who did not undergo carpal tunnel surgery during the study period (part IV).
  • Carpal tunnel syndrome (CTS): percentage of eligible patients with moderate CTS who underwent carpal tunnel surgery, or were offered it and declined (part I).
  • Carpal tunnel syndrome (CTS): percentage of eligible patients with moderate CTS who underwent carpal tunnel surgery, or were offered it and declined (part II).
  • Carpal tunnel syndrome (CTS): percentage of eligible patients with severe CTS who underwent carpal tunnel surgery, or were offered it and declined (part I).
  • Carpal tunnel syndrome (CTS): percentage of eligible patients with severe CTS who underwent carpal tunnel surgery, or were offered it and declined (part II).
  • Carpal tunnel syndrome (CTS): percentage of eligible patients with severe CTS who underwent carpal tunnel surgery, or were offered it and declined (part III).
  • Carpal tunnel syndrome (CTS): percentage of eligible visits for which notes documented whether or not the patient was currently working.
  • Carpal tunnel syndrome (CTS): percentage of eligible visits for which the progress notes documented that the patient was asked about changes in at least one of the following: pain, paresthesias in the first through third digits, or symptoms of hand weakness.
  • Carpal tunnel syndrome (CTS): percentage of eligible visits for which there is documentation in the medical record of the specific job duties or non-occupational activities that are associated with the CTS symptoms.
  • Carpal tunnel syndrome (CTS): percentage of patients with CTS who were pregnant who did not undergo carpal tunnel surgery during the study period, or who met the specified criteria.

Announcements

Notice to Our Users - Redesigned National Quality Measures Clearinghouse (NQMC) Coming Soon!

We are redesigning the NQMC Web site for release this summer! Responsive Web Design (RWD) techniques will provide a better viewing experience across a wide range of devices, from desktop and laptop computers, to tablets and mobile phones.

NQMC Preview

In addition to the new design, NQMC will feature updated searching capabilities by using filters and facets for refining your search results, and updated browsing capabilities for the Browse by Measure Domain and Browse by Organization pages.

The redesigned NQMC Web site will be more intuitive, with an improved, new look and feel, but will maintain the same great content that has defined NQMC for many years. For a preview, visit NQMC.

SAVE THE DATE for the next Guidelines International Network North America (G-I-N/NA) Webinar

Conference News

  • The Guidelines International Network (G-I-N) 13th annual conference will take place from September 27-30, 2016 in Philadelphia. This conference will be co-hosted by the American College of Physicians, ECRI Institute and Penn Medicine. The theme is "Individualised Guidelines and Clinical Performance Measurement in an Era of Personalised Medicine." Deadline for Early Bird Registration is June 20, 2016. For more information, visit the G-I-N Conference Web site.

Health Awareness Topics - May 2016